The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Effect of high-dose Ascorbic acid on vasopressor′s requirement in septic shock
Open accessAbstract
OBJECTIVE: Effects of ascorbic acid on hemodynamic parameters of septic shock were evaluated in nonsurgical critically ill patients in limited previous studies. In this study, the effect of high-dose ascorbic acid on vasopressor drug requirement was evaluated in surgical critically ill patients with septic shock. METHODS: Patients with septic shock who required a vasopressor drug to maintain mean arterial pressure >65 mmHg were assigned to receive either 25 mg/kg intravenous ascorbic acid every 6 h or matching placebo for 72 h. Vasopressor dose and duration were considered as the primary outcomes. Duration of Intensive Care Unit (ICU) stay and 28-day mortality has been defined as secondary outcomes. FINDINGS: During the study period, 28 patients (14 in each group) completed the trial. Mean dose of norepinephrine during the study period (7.44 ± 3.65 vs. 13.79 ± 6.48 mcg/min, P = 0.004) and duration of norepinephrine administration (49.64 ± 25.67 vs. 71.57 ± 1.60 h, P = 0.007) were significantly lower in the ascorbic acid than the placebo group. No statistically significant difference was detected between the groups regarding the length of ICU stay. However, 28-day mortality was significantly lower in the ascorbic acid than the placebo group (14.28% vs. 64.28%, respectively; P = 0.009). CONCLUSION: High-dose ascorbic acid may be considered as an effective and safe adjuvant therapy in surgical critically ill patients with septic shock. The most effective dose of ascorbic acid and the best time for its administration should be determined in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Dombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Carr, A. C., & Frei, B. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1086 · Cited by 940
Does vitamin C act as a pro‐oxidant under physiological conditions?
Carr, A., & Frei, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1007 · Cited by 884
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
Petros, A., Bennett, D., & Vallance, P. (1991) · The Lancet · doi:10.1016/0140-6736(91)92376-d · Cited by 861
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Nursing, M. R. I. C. U., Fowler, A. A., Syed, A. A., Knowlson, S., Sculthorpe, R., Farthing, D., DeWilde, C., Farthing, C. A., Larus, T. L., Martin, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-32 · Cited by 573
Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients
Nathens, A. B., Neff, M. J., Jurkovich, G. J., Klotz, P., Farver, K., Ruzinski, J. T., Radella, F., Garcia, I., & Maier, R. V. (2002) · Annals of Surgery · doi:10.1097/00000658-200212000-00014 · Cited by 536
Effects of a nitric oxide synthase inhibitor in humans with septic shock
Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., & Vallance, P. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.1.34 · Cited by 509
Remick, D. G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060872 · Cited by 501
New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function
Prigge, S. T., Mains, R. E., Eipper, B. A., & Amzel* **, L. M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000763 · Cited by 460
Tanaka, H. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.3.326 · Cited by 438 · cited 5×
“The dose and duration of intervention were selected based on the literature review.[15,17,19,20] Each dose of ascorbic acid was diluted in 50 ml of dextrose 5% solution and was administered as intravenous infusion over 30 min.”
InfluentialDistribution of ascorbic acid, metabolites and analogues in man and animals
Hornig, D. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29271.x · Cited by 438
Circulating vasopressin levels in septic shock
Sharshar, T., Blanchard, A., Paillard, M., Raphael, J. C., Gajdos, P., & Annane, D. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063046.82359.4a · Cited by 413
Vasopressin pressor hypersensitivity in vasodilatory septic shock
Landry, D. W., Levin, H. R., Gallant, E. M., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00012 · Cited by 390
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
Hoffer, L. J., Levine, M., Assouline, S., Melnychuk, D., Padayatty, S. J., Rosadiuk, K., Rousseau, C., Robitaille, L., & Miller, W. H. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn377 · Cited by 375
The Vasopressin System: Physiology and Clinical Strategies
Treschan, T. A., Peters, J., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200609000-00026 · Cited by 316
Schorah, C., Downing, C., Piripitsi, A., Gallivan, L., Al-Hazaa, A., Sanderson, M., & Bodenham, A. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.760 · Cited by 313
Oudemans-van Straaten, H. M., Man, A. M. S.-D., & de Waard, M. C. (2014) · Critical Care · doi:10.1186/s13054-014-0460-x · Cited by 299
Methylene blue administration in septic shock: A clinical trial
Preiser, J.-C., Lejeune, P., Roman, A., Carlier, E., De Backer, D., Leeman, M., Kahn, R. J., & Vincent, J.-L. (1995) · Critical Care Medicine · doi:10.1097/00003246-199502000-00010 · Cited by 263
Terlipressin for norepinephrine-resistant septic shock
O'Brien, A., Clapp, L., & Singer, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08225-9 · Cited by 260
Ascorbic acid dynamics in the seriously ill and injured
Long, C. L., Maull, K. I., Krishnan, R. S., Laws, H. L., Geiger, J. W., Borghesi, L., Franks, W., Lawson, T. C., & Sauberlich, H. E. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00083-5 · Cited by 254
Depletion of neurohypophyseal content of vasopressin in septic shock*
Sharshar, T., Carlier, R., Blanchard, A., Feydy, A., Gray, F., Paillard, M., Raphael, J.-C., Gajdos, P., & Annane, D. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00001 · Cited by 204
Bench-to-bedside review: Vasopressin in the management of septic shock
Russell, J. A. (2009) · Critical Care · doi:10.1186/cc8224 · Cited by 174
Hunt, C., Chakravorty, N., Annan, G., Habibzadeh, N., & Schorah, C. J. (1994) · PubMed · doi:10.5281/zenodo.6406235 · Cited by 170
Morelli, A., Ertmer, C., Rehberg, S., Lange, M., Orecchioni, A., Laderchi, A., Bachetoni, A., D'Alessandro, M., Van Aken, H., Pietropaoli, P., et al. (2008) · Critical Care · doi:10.1186/cc7121 · Cited by 163
Resuscitation After Severe Burn Injury Using High-Dose Ascorbic Acid: A Retrospective Review
Kahn, S. A., Beers, R. J., & Lentz, C. W. (2010) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318204b336 · Cited by 137
Norepinephrine or Dopamine for Septic Shock: Systematic Review of Randomized Clinical Trials
Vasu, T. S., Cavallazzi, R., Hirani, A., Kaplan, G., Leiby, B. E., & Marik, P. E. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066610396312 · Cited by 122
Evaluation of Vitamin C for Adjuvant Sepsis Therapy
Wilson, J. X. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5401 · Cited by 103
Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine
May, J. M., Qu, Z., Nazarewicz, R. R., & Dikalov, S. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.09.009 · Cited by 95
Bornstein, S. R., Yoshida-Hiroi, M., Sotiriou, S., Levine, M., Hartwig, H.-G., Nussbaum, R. L., & Eisenhofer, G. (2003) · The FASEB Journal · doi:10.1096/fj.02-1167fje · Cited by 89
Zanotti-Cavazzoni, S. L. (2008) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(08)70579-3 · Cited by 89
Vitamin C requirement in surgical patients
Fukushima, R., & Yamazaki, E. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833e05bc · Cited by 88
Levine, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38398-9 · Cited by 72
Mak, S. S., & Newton, G. E. (2001) · Circulation · doi:10.1161/01.cir.103.6.826 · Cited by 59
Ascorbic Acid Economy in Surgical Patients as Indicated by Blood Ascorbic Acid Levels
Crandon, J. H., Landau, B. R., Mikal, S., Balmanno, J., Jefferson, M., & Mahoney, N. (1958) · New England Journal of Medicine · doi:10.1056/nejm195801162580301 · Cited by 54
Infectious disease emergencies
Shah, K. H., Lee, J., Medlej, K., & Weingart, S. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139523936.054 · Cited by 53
Parenteral vitamin requirements during intravenous feeding
Lowry, S. F., Goodgame, J. T., Maher, M. M., & Brennan, M. F. (1978) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.12.2149 · Cited by 49
Intravenous ascorbic acid: protocol for its application and use.
Riordan, H. D., Hunninghake, R., Riordan, N. H., Jackson, J. J., Meng, X., Taylor, P. B., Casciari, J. J., González, M. J., Miranda-Massari, J. R., Mora, E., et al. (2003) · PubMed · Cited by 47
Deana, R., Bs, B., Zh, V., & Galzigna, L. (1975) · PubMed · Cited by 37
Holley, A., Osland, E., Barnes, J., Krishnan, A., & Fraser, J. F. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02413.x · Cited by 30
Adrenal failure in the critically ill
Duggan, M., Browne, I., & Flynn, C. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.3.468 · Cited by 30
Effects of Chronic Ascorbic Acid Deficiency on Guinea Pig Lysosomal Hydrolase Activities
Hoehn, S. K., & Kanfer, J. N. (1980) · Journal of Nutrition · doi:10.1093/jn/110.10.2085 · Cited by 26
A rare presentation of an ancient disease: scurvy presenting as orthostatic hypotension
Zipursky, J. S., Alhashemi, A., & Juurlink, D. N. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-201982 · Cited by 24
Catecholamine dependency in a polytrauma patient: relative adrenal insufficiency?
Nieboer, P., van der Werf, T. S., Beentjes, J. A. M., Tulleken, J. E., Zijlstra, J. G., & Ligtenberg, J. J. M. (2000) · Intensive Care Medicine · doi:10.1007/s001340050024 · Cited by 24
Serum vitamin level maintenance in cancer patients on total parenteral nutrition
Kirkemo, A., BURT, M. E., & Brennan, M. F. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/35.5.1003 · Cited by 23
Schneider, F., Kieffer, P., Thannberger, P., Wilhelm, J. M., & Kieffer, C. (2001) · Intensive Care Medicine · doi:10.1007/s001340000830 · Cited by 22
Giusti‐Paiva, A., & Domingues, V. G. D. (2010) · PubMed · Cited by 12
Cited by
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Sepsis and Septic Shock – Basics of diagnosis, pathophysiology and clinical decision making
Font, M. D., Thyagarajan, B., & Khanna, A. K. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.02.011 · Cited by 420
Sepsis-Induced Cardiomyopathy: a Comprehensive Review
L’Heureux, M., Sternberg, M., Brath, L., Turlington, J., & Kashiouris, M. G. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01277-2 · Cited by 383
Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis
Hemilä, H., & Chalker, E. (2019) · Nutrients · doi:10.3390/nu11040708 · Cited by 257
Metadata
- Authors
- Khalili, H., Zabet, M., Mohammadi, M., & Ramezani, M.
- Venue
- Journal of Research in Pharmacy Practice
- Publisher
- Medknow
- Published
- 2016
- Volume
- 5
- Issue
- 2
- Pages
- 94
- ISSN
- 2279-042X (ISSN-L)
- OpenAlex
- W2318294335
- Cited by
- 287
- References
- 49
- FWCI
- 20.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.